Evidence map›Paper›PMID 31741902›Full record

ArticleIndian journal of endocrinology and metabolism

Presentation, Morbidity and Treatment Outcome of Acromegaly Patients at a Single Centre.

Rayees Ul Hamid Wani, Raiz Ahmad Misgar, Moomin Hussain Bhat, Javaid Ahmad Bhat, Shariq Rashid Masoodi, Mir Iftikhar Bashir, Arshad Iqbal Wani

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rayees Ul Hamid WaniDepartment of Endocrinology, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
Raiz Ahmad MisgarDepartment of Endocrinology, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
Moomin Hussain BhatDepartment of Endocrinology, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
Javaid Ahmad BhatDepartment of Endocrinology, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
Shariq Rashid MasoodiDepartment of Endocrinology, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
Mir Iftikhar BashirDepartment of Endocrinology, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
Arshad Iqbal WaniDepartment of Endocrinology, Sheri Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
Sher-i-Kashmir Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe management of acromegaly, a rare and potentially curable disease, has undergone a paradigm shift in the past few decades. Many of the treatment modalities recommended for acromegaly are either too expensive or not available in many parts of India. There is a dearth of treatment and outcome data in Indian patients.

aimOur aim was to study the clinical presentation, hormonal profile, radiology, management, and outcome of the disease at our center. MATERIALS AND

methodsFifty one patients with acromegaly who attended the Department of Endocrinology, SKIMS, Srinagar, between October 2015 and April 2017, were included in the study. Clinical and hormonal profiles, comorbidities, treatment modalities, and outcome were evaluated.

resultsThe gender distribution was equal with the mean age of 42.3 ± 10.9 years at diagnosis. The majority (41) of the patients had macroadenoma. The most common presenting manifestations were acral enlargement and headache. Hypertension was present in 23, musculoskeletal manifestations in 19, and diabetes mellitus in 11 patients. Surgery was the most common method of treatment. Preoperatively only one patient with micro-adenoma had hypocortisolism, which was persistent in postoperative period, while no patient had preoperative or postoperative hypothyroidism or hypogonadism. As per the present consensus criteria, 23.7% patients achieved disease control (40% with microadenoma and only 19.5% with macroadenoma). The surgical complications occurred in 5 patients-CSF leak in 3 meningitis in 2 patients all except one having macroadenoma.

conclusionsThe presentation of disease was generally comparable to that reported in literature. Cure rates were significantly lower than those reported from many large centers.

Indexed as

Acromegalyclinical presentationpituitary macroadenoma

Identifiers

PMID31741902
PMCPMC6844178
OpenAlexW2978819569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.